EXPRES2ION BIOTECH Market Capitalization vs. Current Ratio
| 5JD Stock | EUR 1.77 0.06 3.28% |
For EXPRES2ION BIOTECH profitability analysis, we use financial ratios and fundamental drivers that measure the ability of EXPRES2ION BIOTECH to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well EXPRES2ION BIOTECH HLDG utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between EXPRES2ION BIOTECH's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of EXPRES2ION BIOTECH HLDG over time as well as its relative position and ranking within its peers.
EXPRES2ION |
EXPRES2ION BIOTECH HLDG Current Ratio vs. Market Capitalization Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining EXPRES2ION BIOTECH's current stock value. Our valuation model uses many indicators to compare EXPRES2ION BIOTECH value to that of its competitors to determine the firm's financial worth. EXPRES2ION BIOTECH HLDG is rated below average in market capitalization category among its peers. It is number one stock in current ratio category among its peers . The ratio of Market Capitalization to Current Ratio for EXPRES2ION BIOTECH HLDG is about 3,440,549 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EXPRES2ION BIOTECH's earnings, one of the primary drivers of an investment's value.EXPRES2ION Market Capitalization vs. Competition
EXPRES2ION BIOTECH HLDG is rated below average in market capitalization category among its peers. Market capitalization of Biotechnology industry is presently estimated at about 751.16 Billion. EXPRES2ION BIOTECH adds roughly 44 Million in market capitalization claiming only tiny portion of stocks in Biotechnology industry.
EXPRES2ION Current Ratio vs. Market Capitalization
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
EXPRES2ION BIOTECH |
| = | 44 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
EXPRES2ION BIOTECH |
| = | 12.79 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
EXPRES2ION Current Ratio Comparison
EXPRES2ION BIOTECH is currently under evaluation in current ratio category among its peers.
EXPRES2ION BIOTECH Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in EXPRES2ION BIOTECH, profitability is also one of the essential criteria for including it into their portfolios because, without profit, EXPRES2ION BIOTECH will eventually generate negative long term returns. The profitability progress is the general direction of EXPRES2ION BIOTECH's change in net profit over the period of time. It can combine multiple indicators of EXPRES2ION BIOTECH, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. EXPRES2ION BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 17 people.
EXPRES2ION Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on EXPRES2ION BIOTECH. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of EXPRES2ION BIOTECH position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the EXPRES2ION BIOTECH's important profitability drivers and their relationship over time.
Use EXPRES2ION BIOTECH in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXPRES2ION BIOTECH position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXPRES2ION BIOTECH will appreciate offsetting losses from the drop in the long position's value.EXPRES2ION BIOTECH Pair Trading
EXPRES2ION BIOTECH HLDG Pair Trading Analysis
The ability to find closely correlated positions to EXPRES2ION BIOTECH could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXPRES2ION BIOTECH when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXPRES2ION BIOTECH - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXPRES2ION BIOTECH HLDG to buy it.
The correlation of EXPRES2ION BIOTECH is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXPRES2ION BIOTECH moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXPRES2ION BIOTECH HLDG moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EXPRES2ION BIOTECH can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your EXPRES2ION BIOTECH position
In addition to having EXPRES2ION BIOTECH in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Energy Thematic Idea Now
Alternative Energy
Large and mid-size companies, ETFs and funds that are either investing or directly involved in providing energy derived from sources not connected to fossil fuels, do not consume natural resources, and do not harm the environment. This includes wind power, nuclear and solar energy, biofuel, ethanol, hydrogen and others alternative sources of energy. The Alternative Energy theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Energy Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in EXPRES2ION Stock
To fully project EXPRES2ION BIOTECH's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of EXPRES2ION BIOTECH HLDG at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include EXPRES2ION BIOTECH's income statement, its balance sheet, and the statement of cash flows.